| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1061.94 | 96 |
| GSM780708 | Untreated after 4 days (C2_1) | 1443.1 | 97 |
| GSM780709 | Untreated after 4 days (C3_1) | 1921.64 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 1129.12 | 96 |
| GSM780720 | Untreated after 4 days (C2_2) | 1574.52 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 2051.64 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1487.7 | 97 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1194.56 | 96 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1150.67 | 96 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1443.1 | 97 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1352.65 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1243.62 | 96 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1589.42 | 97 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1275.57 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1361.25 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1650.58 | 97 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1447.62 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1416.39 | 97 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1783.07 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1390.54 | 97 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1408.31 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1517.14 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1380.66 | 97 |